|
Published by: SMI Publishing, Ltd
Published: Oct. 4, 2006
Table of Contents
- Day 1
- 8.30 Registration & Coffee
- 9.00 Chairman's Opening Remarks
- Mr Glen Hodgson, Warehouse & Distribution Director, Baxter Healthcare Limited.
- 9.10 DISTRIBUTION SYSTEMS IN EUROPE WITH AN INTERNATIONAL PERSPECTIVE
- Distribution systems in Europe and the US
- Recent changes in European legislation
- New challenges in the sector
- Services to supply chain partners
- Ms Monika Derecque-Pois, Secretary General, European Association of Pharmaceutical Full Line-Wholesalers (GIRP).
- 9.50 WHY TRADITIONAL WHOLESALING AND DISTRIBUTION WILL BE OBSOLETE IN 5 YEARS
- Not patient any longer
- From veggies to Viagra - a new paradigm for the baby boomer generation
- Doctors - no more heroes anymore
- Curing or healing?
- Complementary and alternative medicine meets with conventional pharmaceuticals in a holistic future
- Mr Glen Hodgson, Warehouse & Distribution Director, Baxter Healthcare Limited.
- 10.30 Morning Coffee
- 11.00 DISTRIBUTION (OR WHOLESALE IN EUROPE?)
- Challenges in the Swiss pharmaceutical supply chain
- Swiss pharmaceutical market supply chain
- Trends (Generika, price reduction a.s.o.)
- Role of wholesaler and pre-wholesaler
- Approach of Galexis to face the challengers
- Mr Bruno Stillhart, Head, Supply Chain Management, Galexis.
- 11.40 PRICING AND PARALLEL TRADE
- Parallel trade in Europe
- What are the current drivers of parallel trade?
- How will other changes in Europe affect parallel trade; e.g. prices, distribution, regulation, expansion?
- Update on counterfeiting issues within Europe
- The future of parallel trade
- Ms Janice Haigh, Principal, IMS Pricing & Reimbursement.
- 12.20 CHANGES TO MEDICINES REGULATION IN EUROPE
- New requirements for wholesale dealers
- The 2001 review and amending directives
- Veterinary medicines regulations 2005 SI 2745
- Risk based approach to inspection
- Commonly seen deficiencies
- Mr Richard Andrews, Operations Manager, MHRA.
- 1.00 Networking Lunch
- 2.30 UNLICENCED MEDICATIONS - UK PERSPECTIVE
- Risk management and its implications - a customer view
- Why are unlicensed medications allowed for use?
- Using free medications as a promotional tool for new drugs
- How do hospitals benefit from unlicensed medications?
- How are unlicensed drugs distributed?
- What are the risks?
- Why are current controls so limited?
- Should a European standard be created?
- Mr Allan Karr, Pharmacy Business Services Manager, UCL Hospitals Foundation Trust (NHS).
- 3.10 Afternoon Tea
- 3.30 THE IMPACT OF ELECTRONIC PRESCRIPTION
- The experience in Catalonia
- Wholesalers and home-care providers
- Enabling deliveries straight to the patient
- Training patients to self-administer
- Packaging requirements
- Preventing scheduling and efficiency issues
- Dr Antoni Gilabert, Director Pharmaceutical Care & Complementary Benefits, Catalan Health Service.
- 4.50 THE EUROPEAN PHARMACEUTICAL SUPPLY CHAIN
- Distribution integrity and patient safety
- The fragmented supply chain in Europe and lack of effective batch recall has serious patient safety implications
- This fragmentation is providing an easy route to market for counterfeiters
- Margin management and human error in re-packaging are detrimental to patient outcomes
- Manufacturer’s need to secure their route to market for the benefit of their patients
- Mr Andrew Richmond, Associate Director, European Commercial Distribution, Pfizer Ltd.
- 5.30 Chairman’s Closing Remarks and Close of Day One
- Day 2
- 8.30 Registration & Coffee
- 9.00 Chairman's Opening Remarks
- Dr Christian Borel, European Distribution Manager, Serono Pharmaceutical Research Institute.
- 9.10 ELECTRONIC PEDIGREE SYSTEMS
- Changing the face of European distribution?
- About GS1 & the European Healthcare Initiative
- The key role of standards in pharmacy distribution systems
- The development of Electronic Pedigree systems
- European Healthcare Initiative's ePedigree Pilot
- The implications for European pharmacy distribution
- Mr John Jenkins, Consultant, GS1 Europe - European Healthcare Initiative.
- 9.50 BUILDING THE BEST BIOTECH SUPPLY CHAIN IN EUROPE
- Case study: Serono
- European distribution project (2003-2004)
- Outsourcing warehousing and distribution to 3PL
- - Insourcing customer service
- Monitoring and improving performance
- - Compliance
- - Service
- - Costs
- - Leveraging European distribution assets
- Dr Christian Borel, European Distribution Manager, Serono Pharmaceutical Research Institute.
- 10.30 Morning Coffee
- 11.00 PHARMACEUTICAL DISTRIBUTION IN SOUTH AFRICA
- A manufacturer's perspective
- A brief history of pharmaceutical distribution
- Our experiences over the past 20 years
- Where are we today?
- How do we see the future?
- Mr Anton Potgieter, Director Planning and Technical Affairs, Boehringer Ingelheim.
- 11.40 THE NEED TO FIND A NEW AND MORE EFFECT METHODOLOGY OF DISTRIBUTION OF SPECIALISED PHARMACEUTICALS TO PATIENTS
- Exploring the supply chain
- Why the need to establish different supply chains?
- What types of products are we considering for this new supply chain?
- What types of specialisation will become necessary?
- Funding implications?
- Advantages and disadvantages of the supply chain
- Mr Graham Somerville, CEO, International Healthcare Distributors.
- 12.20 NOT ALL DRUGS AND DISPENSED HOME DELIVERY PROVIDERS ARE THE SAME
- Size, scale and development of home delivery in the marketplace
- Gathering and sharing of data will promote compliance and reduce patient drop off
- How to create a new relationship with clinicians and nurses to make a product stand out
- How proactive real time management can improve service to patients
- How to ensure through real time measurements that your high value chill products are delivered at ideal temperatures
- Mr Simon French, Director, Business Development, Healthcare Logistics Ltd.
- 1.00 Networking Lunch
- 2.20 TRACABILITY OF THE PHARMACEUTICAL SUPPLY CHAIN
- Problems and requirements
- Data flow and database
- Technological alternatives
- Where to go from here?
- Mr Andre Grigjanis, Managing Director, GCC Pharma/IBS.
- 3.40 TEMPERATURE MONITORING OF MEDICINAL PRODUCTS DURING STORAGE AND TRANSPORTATION
- Temperature validation and qualification of pharmaceuticals in the Supply Chain
- Considerations when carrying out temperature mapping of storage facilities
- Temperature monitoring of storage facilities; using RF technology
- Validation vs. Qualification
- Carrying out route qualifications of pharmaceutical supply chains
- Miss Anna Woodward, Regional Manager, Trackflow Ltd.
- 4.20 Afternoon Tea
- 4.20 Chairman’s Closing Remarks and Close of Conference
AbstractAs the European pharmaceutical market becomes increasingly integrated the impact on the wholesale and distribution of pharmaceuticals needs to be revisited. The next five year’s will witness radical transformation and by keeping up to date with this, our 9th Annual European Pharmaceutical Wholesale & Distribution conference will provide essential information for companies wishing to compete and succeed in the supply chain of the future.
This conference assesses the changing trends in wholesale and distribution, exploring insights into new products and new product offerings, discovering the true economics of pharmaceutical distribution, whilst displaying current and future business models for distribution in Europe along with other global pharmaceutical markets. This event will also provide you with a good understanding of the changing regulatory climate, ensuring you are up to date with the latest policies affecting you and your business.
Speakers at this year's event include:
- Speakers at this year's event include:
- Andrew Richmond, European Associate Director, Pfizer
- Paul Stewart, Chief Executive Officer, Boehringer-Ingelheim
- Dr Christian Borel, European Distribution Manager, Serono
- Richard Andrews, Operations Manager, Medicines & Healthcare products Regulatory Agency (MHRA)
- Graham Somerville, Chief Executive Officer, International Healthcare Distribution (IHD)
- Monika Derecque-Pois, Secretary General, European Association of Pharmaceutical Full - Line Wholesalers (GIRP)
- Dr Antoni Gilabert, Director, Pharmaceutical Care & Complimentary Benefits, Catalan Health Service
- Allan Karr, Pharmacy Business Services Manager, UCL Hospitals Foundation Trust(NHS)
- Bruno Stillhart, Head, Supply Chain Management, Galexis
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
